⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEXX News
Lexaria Bioscience Corp. Common Stock
Lexaria Updates Business Development
accessnewswire.com
LEXX
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
accessnewswire.com
LEXX
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
accessnewswire.com
LEXX
GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand
accessnewswire.com
LEXX
NVO
LLY
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
accessnewswire.com
LEXX
LLY
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
accessnewswire.com
LEXX
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
accessnewswire.com
LEXX
Lexaria Bioscience Releases Second Episode of Investor Video Series
accessnewswire.com
LEXX
Lexaria Updates Progress on Human Study #7
accessnewswire.com
LEXX
XXII
Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications
accessnewswire.com
LEXX